WuXi Says Expects Charles River Laboratories (Massachusetts) Deal to Close by Q4

Reuters -- Drug research services provider WuXi PharmaTech Inc (WX.N), whose proposed buyout by U.S. rival Charles River Laboratories International Inc (CRL.N) is seeing active opposition from Charles River investors, said it still expects the deal to close by the fourth quarter.

Back to news